Navigation Links
Senate HELP Committee OKs Food and Drug Administration Safety And Innovation Act
Date:4/25/2012

WASHINGTON, April 25, 2012 /PRNewswire-USNewswire/ -- The Senate Health, Education, Labor and Pensions Committee approved the Food and Drug Administration Safety and Innovation Act today. While the legislation includes some improvements over current law, it leaves many significant flaws with the FDA's current medical device oversight system unaddressed, according to Consumers Union, the policy and advocacy arm of Consumer Reports.

"The FDA's current fast track review process has allowed too many dangerous and defective devices onto the market," said Lisa McGiffert, director of Consumers Union's Safe Patient Project. "To make matters worse, the FDA doesn't have the tools it needs to react quickly when safety problems with medical devices arise. Unfortunately, this bill doesn't fix some of the most serious flaws in our current system and leaves patients at risk."

Consumers Union had urged the Committee to strengthen the bill by prohibiting the clearance of new medical devices based on recalled ones; improving the system for monitoring devices once they are cleared for sale; providing the FDA with greater authority to require post-market safety studies; and retaining current strong conflict of interest standards.

For more details, see Consumers Union's news release outlining these concerns.


'/>"/>
SOURCE Consumers Union
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Senate Told Brain Technology Can Impact Public Policy
2. Senate Introduces Bill to Boost Participation in Clinical Trials for Rare Diseases
3. AST on Capitol Hill to Promote Transplant Drug Extension Provision With Senate as Part of Health Care Reform
4. PhRMA Statement on Senate Finance Committee Vote
5. Senate Rejects Bulk Imports of Medicine from Canada, but Personal Importation Remains a Popular Option for U.S. Citizens
6. Physician Groups Oppose Current Senate Health Care Reform Bill
7. RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgans Drug Importation Plan Puts Seniors at Risk
8. GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia
9. World TB Day Senate Briefing
10. NACDS, NCPA Back Senate Medication Therapy Management Bill
11. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 /PRNewswire/ ... SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the ... by 45.3% compared to placebo (1.63 vs 2.98, p=0.010) ... Novartis today announced that the data are being featured ... American Society of Hematology (ASH) Annual Meeting and ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... Aliso Viejo, California (PRWEB) , ... December 04, ... ... self-animating lower third presets that have new attractive animation styles with unique displacement ... Pro3rd Displace features 30 pre-animated lower third designs. Choose from a variety of ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of ... Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, ... Jason brings extensive financial and operational leadership experience to Advanced Inc. He began his ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
Breaking Medicine News(10 mins):